(Q39453775)

12 September 2017

Open label gabapentin treatment for pain in multiple sclerosis (English)

1 reference

12 September 2017

0 references

0 references

M K Houtchens

1

1 reference

12 September 2017

J R Richert

series ordinal

2

1 reference

12 September 2017

A Sami

series ordinal

3

1 reference

12 September 2017

J W Rose

series ordinal

4

1 reference

12 September 2017

1 August 1997

1 reference

Multiple Sclerosis Journal

12 September 2017

1 reference

12 September 2017

3

1 reference

12 September 2017

4

1 reference

12 September 2017

250-253

1 reference

Acute and chronic pain syndromes in multiple sclerosis

12 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

Pain syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

Phenytoin: mechanisms of its anticonvulsant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

Comparative pharmacokinetics of the newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300407

10.1177/135245859700300407

21 January 2018

Identifiers

DOI

1 reference

release_62rodnxy5jderev6zia3qv4bfu

12 September 2017

0 references

1 reference